Gossypol


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1000 CDH2 Decreases expression PMID:15082077; PMID:39263880
10018 BCL2L11 Increases expression PMID:18840529
1499 CTNNB1 Decreases expression PMID:39263880
211 ALAS1 Increases activity PMID:15027808
2247 FGF2 Decreases expression PMID:19825521
2261 FGFR3 Decreases expression PMID:19825521
2697 GJA1 Decreases expression PMID:15082077
27113 BBC3 Increases expression PMID:18840529
3162 HMOX1 Increases activity PMID:15027808
3397 ID1 Decreases expression PMID:19825521
4170 MCL1 Decreases expression PMID:18840529; PMID:20587533; PMID:21750559
4192 MDK Decreases expression PMID:19825521
4313 MMP2 Decreases activity PMID:39263880
4313 MMP2 Decreases expression PMID:39263880
5328 PLAU Decreases activity PMID:39263880
598 BCL2L1 Affects activity PMID:16020667
598 BCL2L1 Decreases expression PMID:18840529
6347 CCL2 Decreases expression PMID:19825521
7431 VIM Decreases expression PMID:39263880
836 CASP3 Increases activity PMID:19825521
840 CASP7 Increases activity PMID:19825521
999 CDH1 Increases expression PMID:39263880

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.